Original Articles

    Original Articles should describe research as concisely as possible, without sacrificing the full documentation of results. They should fit within the subject categories described below and meet the editorial standards described in these Instructions to Authors.

     • Biology and Immunology of Hematolymphoid Tissues
     • Reactive, Infectious, and Lymphoproliferative Disorders
     • Laboratory Methodologies and Technologies
     • Lymphomas and Lymphoid Leukemias
     • Myeloma/Plasmacytoma
     • Lymphoproliferative Disorders (Other Than Overt Neoplasms)
     • Myeloid Leukemia, Myelodysplastic Syndrome, and Myeloproliferative neoplasms
     • Histiocytic and Dendritic Cell Neoplasms

    The journal also offers fast-track publication for Original Articles presenting novel findings of high importance, as well as those judged to be of highest priority. Fast Track manuscripts are selected by the Editors based on their judgment and reviewer recommendations. They are published sooner than regular manuscripts.

    Review Articles

    Review Articles are primarily commissioned by the Editors. In exceptional circumstances, the Editors will consider unsolicited Review Articles. A pre-submission inquiry describing the proposed article must be sent to the Editors before full submission. Based on their assessment of the review’s potential interest to the journal’s readership, the Editors will then decide whether to invite submission of the full review.

    Case Reports

    Case Reports describe hematolymphoid diseases and must provide new information.

    Short Communications

    Short Communications describe pertinent and interesting observations or studies concerning hematolymphoid research that do not warrant publication as an Original Article.

    Letters to the Editor

    Letters to the Editor comment on published papers and controversial issues, including negative data that are of general interest or data that contradict commonly accepted concepts or hypotheses. The Editors may invite Letters describing pertinent and interesting observations concerning hematolymphoid research in general, reporting on new observations or pilot studies that do not justify an Original Article, or commenting on published papers. In the case of Letters commenting on a published paper, the Editors may invite the authors of the paper to respond. Both letters may then be published, if the Editors judge them to be of interest to the journal’s readership.